Methodology

All entries for: Iyuda Therapeutics Inc.

April 20, 2026

Iyuda Therapeutics Inc.

Orphan Drug Designation

treatment of acute myeloid leukemia

Disease Area: Rare Diseases
Source
Scroll to Top